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Abstract
Amongst the most severe clinical outcomes of life-long infections with Helicobacter pylori is the development of peptic
ulcers and gastric adenocarcinoma - diseases often associated with an increase of regulatory T cells. Understanding H.
pylori-driven regulation of T cells is therefore of crucial clinical importance. Several studies have defined mammalian
microRNAs as key regulators of the immune system and of carcinogenic processes. Hence, we aimed here to identify H.
pylori-regulated miRNAs, mainly in human T cells. MicroRNA profiling of non-infected and infected human T cells revealed
H. pylori infection triggers miR-155 expression in vitro and in vivo. By using single and double H. pylori mutants and the
corresponding purified enzymes, the bacterial vacuolating toxin A (VacA) and c-glutamyl transpeptidase (GGT) plus
lipopolysaccharide (LPS) tested positive for their ability to regulate miR-155 and Foxp3 expression in human lymphocytes;
the latter being considered as the master regulator and marker of regulatory T cells. RNAi-mediated knockdown (KD) of
the Foxp3 transcription factor in T cells abolished miR-155 expression. Using adenylate cyclase inhibitors, the miR-155
induction cascade was shown to be dependent on the second messenger cyclic adenosine monophosphate (cAMP).
Furthermore, we found that miR-155 directly targets the protein kinase A inhibitor a (PKIa) mRNA in its 39UTR, indicative
of a positive feedback mechanism on the cAMP pathway. Taken together, our study describes, in the context of an H.
pylori infection, a direct link between Foxp3 and miR-155 in human T cells and highlights the significance of cAMP in this
miR-155 induction cascade.
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Introduction
Helicobacter pylori is a Gram-negative microaerophilic bacterium
estimated to colonize more than half the world’s population. It
typically establishes a life-long infection within the stomach, where
it induces a marked immune response with local infiltration of
neutrophils, lymphocytes and macrophages. H. pylori is the main
cause of peptic ulceration (15% of infections) and gastric
adenocarcinoma (0.5 to 2% infections) (for review, see [1] and it
has been shown to cause B cell mucosa associated lymphoid tissue
(MALT) lymphoma [2]. While several mechanisms involved in
adenocarcinoma induction have been described, the mechanisms
underlying the onset of other H. pylori-implicated lymphomas
remain obscure.
MicroRNAs (miRNAs) are non-protein coding ,22 nucleotide
RNAs that induce translational repression and/or degradation of
their mRNA targets [3,4]. Many miRNAs are differentially
regulated in cancer, for example, miR-34a is involved in p53-
mediated apoptosis in pancreatic cancer [4–6]; in primary breast
cancer, nine miRNAs were up-regulated, including miR-21, miR-
181b and miR-155 [7]. The implication of miRNAs in cancer
development is particularly true for the let-7 family members.
Convergence of abundant in vitro and in vivo data has identified
these miRNAs as tumor-suppressors that regulate multiple
oncogenes such as Ras, Myc or HMGA-2 (reviewed in [8]).
A growing body of evidence suggests bacterial and viral
infection of mammalian and plant cells can modulate miRNA
expression [9]. In mammalian cells, the Epstein-Barr virus (EBV)
has been shown to trigger miR-21, miR-155 and miR-146a
expression [10], which might play a role in the development of
EBV associated Burkitt’s lymphoma. Treatment of immune cells
with bacterial lipopolysaccharide (LPS; Salmonella and Escherichia
coli) led to the induction of miR-155, miR-132 and miR-146a
expression [11]. Other studies have reported the induction of miR-
155 expression in murine primary macrophages by a range of toll-
like receptor ligands [12] and that LPS stimulation can also lead to
the down-regulation of miRNAs such as miR-125b, as demon-
strated in murine macrophages and C57Bl6 mice [11]. Most
recently, induction of miR-155 expression upon H. pylori infection
of gastric epithelial cells and tissues has been reported [13]. T cells
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lymphoma initiation. To date, however, there has been no study of
the regulation of miRNAs by H. pylori in T cells.
H. pylori harbours several virulence factors (for review, see
[1,14]) that contribute to the genesis of inflammation. Important
virulence factors are the cagPAI, encoding a type IV secretion
system, the vacuolating cytotoxin (VacA), responsible for vacuo-
lation, apoptosis and inhibition of Interleukin (IL-2) secretion in T
cells [15,16] and the c-glutamyl transpeptidase (GGT), which
inhibits T cell proliferation [17].
Here, we investigated the differential regulation of miRNAs by
the carcinogenic bacterium H. pylori mainly in T cells, and the
underlying bacterial and host mechanisms associated with their
regulation during the course of an infection. Our results revealed
that miR-155 is up-regulated upon H. pylori infection in vitro and in
vivo, and its activation is under control of the Foxp3 transcription
factor in T cells. We also identified bacterial factors that mediate
miR-155 expression. Furthermore, we provide evidence that
intracellular cyclic adenosine monophosphate (cAMP) is a key
component of this bacterial activation and that miR-155 targets
protein kinase A inhibitor a (PKIa) in order to further increase
cAMP production.
Results
H. pylori Induces Up-Regulation of miR-155 Expression in
Different Cell Lines
To examine whether H. pylori regulates miRNA expression in T
cells, a microarray analysis of 248 mature miRNAs of human and
murine origin was conducted with the human T cell line Jurkat.
Regulation of miRNAs has been previously reported in epithelial
cell lines [13,18], therefore we sought to substantiate these findings
in two different human epithelial cell lines (AGS and MKN74).
We also compared the regulation response within a murine
macrophage cell line (J774a). The cells were infected for 3 hours
with two different strains of H. pylori (P12 and Hp76) depending on
their human or murine origin, respectively. In both epithelial cell
lines (AGS and MKN74), a mild up-regulation (,2-fold) of miR-
26a was observed. In the macrophage cell line J774a, murine miR-
292-5p, miR-298 and miR-290 were up-regulated 2.7-, 2.2- and 2-
fold, respectively. In Jurkat cells, only miR-155 was up-regulated
(3.3-fold). Up-regulation of miR-155 was approximately 3-fold in
J774a and MKN74 cells, and 7.5-fold in AGS cells (microarray
deposited data, GSE18616). Since miR-155 was the only common
miRNA significantly induced by H. pylori in all tested cell lines, it
was selected for further analysis.
Next, we measured miR-155 expression in vivo, using human
gastric biopsies. Four patients, initially negative for H. pylori
infection (= day 0), were challenged with a H. pylori strain lacking
a functional cagPAI [19,20]. Eighty days post-infection (p.i.) (day
80), biopsies containing a mixture of immune and non-immune
cells were taken from the antrum of the volunteers and RNA was
extracted. The relative numbers of cell types were quantified by
real time RT-PCR detection of specific cellular markers such as
cytokeratin 18 (epithelial cells), CD3 (T lymphocytes) and CD11c
(macrophages and dendritic cells). Numbers of epithelial or T cells
did not change substantially during infection with H. pylori over 80
days; however, macrophages and/or dendritic cells were strongly
recruited to the site of inflammation (up to 16-fold increase; Figure
S1). Comparison of miR-155 expression levels in each patient
before (day 0) and after infection (Day 80) revealed a strong up-
regulation (up to ,13-fold) of miR-155 (Fig. 1A), indicating that
cagPAI is unnecessary for miR-155 induction.
To further validate our observations, infections with the wild
type H. pylori strains P12 and Hp76 were performed in the same
four cell lines, plus primary murine derived macrophages
(BMDM) isolated from C57Bl6 mice. Quantitative-PCR (qPCR)
analysis of miR-155 expression confirmed our microarray data
(Fig. 1B), even when a lower multiplicity of infection (MOI) was
used (MOI 10 and 50; data not shown). Northern blotting and
qPCR revealed a clear up-regulation of miR-155 by H. pylori in
J774a cells (data not shown). Since miR-155 is expressed at low
levels in T cells [21], it was not detectable using Northern blotting.
Instead, we used qPCR to confirm miR-155 induction in Jurkat
cells and another T cell line, CCRF-CEM (Fig. 2A). Expression
kinetics of miR-155 in Jurkat cells were monitored over a 12 h
infection time course, revealing a sharp up-regulation of miR-155
expression at 3 h p.i., which continued to increase until 6 h p.i.,
before gradually declining to levels comparable to non-infected
cells by 12 h p.i. (Fig. 2B).
Figure 1. H. pylori induces miR-155 expression in vivo and in vitro. (A) In vivo analysis of miR-155 expression in human gastric biopsies. Total
RNA extracted from the antrum of four patients before and after 80 days of infection (patient 13, 29, 71 and 77) and analysed by qPCR was used to
show the induction of miR-155 expression by H. pylori in the gastric mucosa. (B) miR-155 expression in primary murine macrophages (Bone Marrow
Derived Macrophages), J774a, AGS and MKN74 cell lines after H. pylori infection (MOI 100, 3 h) as monitored by qPCR. Murine cells (BMDM and J774a)
were infected with Hp76 strain while human cells (AGS and MKN74) were infected with the P12 strain. Results are expressed as a ratio between
infected and non-infected samples. Error bars show standard deviation (SD) of three independent experiments.
doi:10.1371/journal.pone.0009500.g001
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Since miR-155 induction can occur after LPS treatment of
macrophages [11,12], we tested whether H. pylori LPS regulates
miR-155 expression. CCRF-CEM cells were incubated with
purified H. pylori LPS (500 ng/ml) and miR-155 expression was
assessed by qPCR. E.coli LPS (100 ng/ml) and whole live H. pylori
(P12) were used as positive controls. Heat-inactivated H. pylori (HI
P12) was used to test whether miR-155 induction occurs via a
passive or an active mechanism. All stimuli induced miR-155
expression to a similar extent (,3-fold increase) (Fig. 3A),
suggesting that miR-155 induction by H. pylori is partially LPS
dependent.
Induction of miR-155 Expression Is VacA and GGT
Dependent
The mouse-adapted strain Hp76 induces miR-155 up-regula-
tion in macrophages (see Fig. 1B). Since this strain does not
possess a functional cagPAI (Figure S2), we concluded that
cagPAI is not necessarily required for induction of mir-155. To
identify the bacterial factors that could be responsible for miR-
155 induction in T cells, we investigated the role of two key
virulence proteins, VacA and GGT, known to affect T cell
function in terms of IL-2 secretion and proliferation [15,17]
(Fig. 3B). Expression of miR-155 was measured by qPCR after
infection of CCRF-CEM cells with either single mutants of H.
pylori (P12DvacA,P 1 2 Dggt) or the double mutant (P12DvacADggt).
In all mutants tested, miR-155 induction was decreased in
comparison to the wild type H. pylori. In mutants lacking GGT,
this decrease was most pronounced (,3-fold) (Fig. 3B). However,
when cells were incubated with the purified VacA and GGT
proteins, miR-155 expression increased 2.5 to 3-fold (Fig. 3B).
Protein concentrations used were similar to those previously
reported for the inhibition of IL-2 secretion and proliferation
[15,17]. Since the GGT protein was obtained as a recombinant
enzyme from E. coli and hence was possibly contaminated by
bacterial LPS, we co-incubated cells with the GGT inhibitor
acivicin, prior to GGT treatment. Consequently, miR-155
induction was abolished (Fig. 3B). Acivicin treatment did not
affect cell viability at the used concentration, as confirmed by the
WST1 viability assay (Figure S3). Heat inactivation of GGT (HI
GGT) or the use of a mutant lacking catalytic activity (GGTm)
demonstrated that only the active catalytic form of GGT can
induce miR-155 expression. These results indicate that miR-155
induction depends on multiple bacterial factors, some of which
are already known as key players in H. pylori virulence.
miR-155 Expression Is Foxp3-Dependent
Next, we investigated the role of host cell factors in the up-
regulation of miR-155. Since the transcription factor Foxp3 is
reported to bind the miR-155 promoter in primary murine CD4
+
CD25
+T cells [22], we speculated Foxp3 may regulate miR-155
expression. First we analysed Foxp3 expression in vivo, using
biopsies from the four human volunteers. Both Foxp3 and miR-
155 expression were up-regulated by up to ,13-fold (Fig. 4A),
indicating that H. pylori is able to trigger Foxp3 expression.
Upon infection of CCRF-CEM cells with H. pylori, H. pylori LPS
or GGT, Foxp3 mRNA levels were increased (,6.4-, ,13- and
,24-fold increase, respectively; Fig. 4B). At the protein level, H.
pylori elicited a 1.7-fold up-regulation of Foxp3 at 3 h p.i. (Fig. 4C).
We validated these results using primary cells (PBMCs) from five
human donors negative for any previousH. pyloriinfection(Fig. 4D).
Foxp3 mRNA induction was observed 6 h after H. pylori infection or
GGT treatment in all donors. To demonstrate that Foxp3 is directly
involved in miR-155 induction, we induced a transient knockdown
(KD) of Foxp3 (#Foxp3) in non-infected and P12-infected CCRF-
CEM cells using RNA interference (,80% KD). No up-regulation
of miR-155 was detected (Fig. 4E), indicating that Foxp3 KD
abolished expression of this miRNA in CCRF-CEM cells. Similar
data were obtained for Jurkat cells (data not shown). Taken
together, these data indicate a strong correlation between Foxp3
and miR-155 expression in vivo and in vitro.
cAMP Pathway Dependent Regulation of Foxp3 and
miR-155 Expression
Foxp3 expression is thought to be regulated by the CREB
transcription factor [23]. Since CREB is phosphorylated by
Protein Kinase A (PKA), which is activated by cAMP [24], we
measured intracellular cAMP levels in T cells (Jurkat) after 30 min
of infection with wild type and mutant H. pylori strains (Fig. 5A).
The adenylate cyclase (AC) agonist, forskolin, served as a positive
control. Intracellular cAMP levels were drastically increased after
infection with the wild type H. pylori, in comparison to the mutant
Figure 2. H. pylori induces miR-155 expression in vitro. (A) Results of qPCR of miR-155 expression in Jurkat and CCRF-CEM cell lines after H.
pylori infection (MOI 100, 3 h). Data are mean 6SD of three independent experiments. (B) Kinetics of miR-155 expression upon H. pylori infection in
Jurkat cells. Total RNA was extracted from cells infected with the P12 strain and non-infected cells at different time points (1 h, 3 h, 6 h, 9 h,12 h) and
assayed for miR-155 by qPCR. Results are expressed as a ratio between infected and non-infected samples. Results are normalized to expression levels
of the small RNA U6 (RNU6B), which remains unchanged by the bacterial stimulus. Error bars show SD of at least three independent experiments.
doi:10.1371/journal.pone.0009500.g002
miR-155 Induction by H. pylori
PLoS ONE | www.plosone.org 3 March 2010 | Volume 5 | Issue 3 | e9500strains. Absence of VacA protein and GGT enzyme prevented, or
at least severely restricted, induction of cAMP, indicating that the
H. pylori-induced elevation of cAMP is VacA- and GGT-
dependent. Next, we investigated whether cAMP induction is
involved in Foxp3 and miR-155 expression by incubating CCRF-
CEM cells with the AC agonist PGE2. PGE2 induced an increase
in Foxp3 mRNA levels and miR-155 expression after 3 h of
incubation; the level of up-regulation after PGE2 addition was
comparable to that observed after H. pylori infection (Fig. 5B).
These results demonstrated that AC is activated, indicating that
the cAMP pathway induces Foxp3 and miR-155 expression. To
further substantiate our results, T cells were incubated with an
irreversible inhibitor of AC, MDL-12330A, 1 h before infection
with H. pylori. After blockage of the cAMP pathway, Foxp3 protein
expression decreased, as shown by Western blot and FACS
(Fig. 5C and D). In the presence of the inhibitor, miR-155
expression decreased by 75% after H. pylori treatment, as
measured by qPCR (Fig. 5E). Thus, our findings show that the
cAMP cascade is involved in Foxp3 induction and subsequent
miR-155 expression in T cells upon H. pylori infection.
H. pylori and miR-155 Induced Over-Expression
Down-Regulates PKIa Levels
cAMP mediates a diverse array of cellular responses by
activating PKA. Activation of PKA occurs when cAMP binds to
the two regulatory subunits of PKA resulting in the release of the
two catalytic subunits [25,26]. We found PKIa protein levels
decreased 3 h after H. pylori infection of T cells in a GGT- and
Figure 3. H. pylori induces miR-155 expression in an LPS, VacA- and GGT-dependent manner. (A) CCRF-CEM were co-cultured with live or
heat inactivated (HI) H. pylori (P12, MOI 100, 3 hours) or incubated with purified E.coli and H. pylori LPS (100 and 500 ng/ml). miR-155 expression was
then measured by qPCR. Results are normalized to expression levels of RNU6B. (B) CCRF-CEM cells were infected with the wild type strain P12, the
single mutants (P12dvacA and P12dggt) and the double mutant (P12dvacAdggt) at an MOI of 100 for 3 h. The T cells were also incubated with the
purified enzyme VacA and its buffer. The GGT enzyme was tested for miR-155 expression with or without the GGT inhibitor (acivicin). Acivicin
treatment alone did not affect miR-155 expression. A mutant form of the GGT (GGTm) and the heat-inactivated protein (HI GGT) were negative for
miR-155 induction. Results in (A) and (B) are expressed as a ratio between infected and non-infected samples. Error bars show SD of at least two
independent experiments. * p value#0.05.
doi:10.1371/journal.pone.0009500.g003
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in this down-regulation, miR-155 was transiently over-expressed
in T cells (,4250-fold increase of miR-155) (Fig. 7A). Over-
expression induced a dramatic decrease of the PKIa protein level
showing that the effect is mediated by miR-155 (Fig. 7A). The
bioinformatic database PicTar (http://pictar.mdc-berlin.de/) pre-
dicts miR-155 targets human PKIa and the core binding sequence
has a 7-mer match in the 39UTR (Fig. 7B). Therefore, we
speculated that miR-155 directly targets PKIa. Hence, we
performed a luciferase reporter assay after generating a construct
in which the firefly luciferase mRNA is fused to the 39U ´TR of
PKIa (PKIa UTR). HEK 293T cells were first co-transfected with
the miR-155 precursor or the miR-141 precursor (negative
control) or another negative control precursor (NC). At 16 h post
transfection, cells were then co-transfected with the Renilla
luciferase-containing plasmid (pRLSV40) for normalisation and
the PKIa UTR plasmid. To assess miR-155 over-expression, an
indicator plasmid containing the complementary sequence of
miR-155 fused to the firefly luciferase (miR-155 indicator) was
simultaneously transfected. Following miR-155 transfection lucif-
erase activities of both the indicator plasmid and the 39UTR of the
PKIa reporter were reduced (,48% and ,36%, respectively) in
comparison to the negative control precursor, indicating successful
miR-155 over-expression (Fig. 7C). Over-expression of miR-141
did not affect luciferase activity encoded by the PKIa reporter.
Thus, we conclude PKIa is a direct functional target of miR-155.
Discussion
While gastric cancer has been strongly linked to the H. pylori
CagA protein [27], the mechanisms underlying other carcinogenic
outcomes, such as MALT lymphoma, are poorly understood.
Figure 4. miR-155 expression in T cells is dependent on the H. pylori-mediated induction of Foxp3. (A) In vivo analysis of Foxp3
expression in human gastric biopsies. Total RNA extracted from the antrum of four patients before and after 80 days of infection (patient 13, 29, 71
and 77) was used for the measurement of Foxp3 expression by qPCR. (B) Total RNA from CCRF-CEM cells was assayed for Foxp3 mRNA expression
after H. pylori infection or incubation with H. pylori LPS and GGT, and compared to non-infected cells. qPCR data show an induction of Foxp3 after
challenge with live bacteria, LPS and purified GGT. Data are mean 6SD of two independent experiments. (C) Western blot analysis of Foxp3 protein
induction in CCRF-CEM cells infected with H. pylori (P12, 3 h). Actin serves as a loading control. Foxp3 band intensities shown. Blots are representative
of two independent experiments. (D) Human PBMCs were assayed by qPCR for Foxp3 expression after H. pylori infection or GGT treatment over time
(1 to 6 h). The results obtained from 5 individual donors show an increase of Foxp3 mRNA after 6 h. (E) miR-155 expression was measured by qPCR in
the Foxp3 KD CCRF-CEM cells at 3 h p.i. Results are expressed as a ratio between infected and non-infected samples. Error bars show SD of two
independent sets of experiments. Foxp3 (#Foxp3) KD was achieved using siRNA technology and confirmed by Western blot 48 hours post-
transfection.
doi:10.1371/journal.pone.0009500.g004
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lymphomas [28], we investigated the differential induction of
miRNAs after H. pylori infection in T cells. Interestingly, our
microarray screen identified miR-155, the functional product of
an exon within the non-protein coding gene bic (B-cell integration
cluster) [29], as the only miRNA induced in Jurkat cells. It was the
only commonly activated miRNA in different cell lineages 3 h post
infection with H. pylori. Up-regulation of miR-155 was validated in
primary monocytes after stimulation with H. pylori, as well as in vivo
by testing human gastric biopsies from patients that had previously
participated in a clinical H. pylori challenge study [19].
We investigated the role of key bacterial endotoxins and
virulence factors as well as host signalling processes in the
expression of miR-155. Consistent with previous findings for
macrophages [12] and dendritic cells [30,31], here we demon-
strated that miR-155 expression in lymphocytes is induced by H.
pylori LPS. We also observed that the H. pylori-specific virulence
factors VacA and GGT are necessary for the full induction of
miR-155. VacA is a secreted pore-forming protein that interferes
Figure 5. Foxp3 and miR-155 expression are mediated by cAMP induction in T cells. (A) Intracellular levels of cAMP were measured in
Jurkat cells after 30 min of forskolin treatment (positive control) or H. pylori infection (wild type strain P12 and the mutants dggt and dvacA). (B)
Activation of ACs induces Foxp3 and miR-155 expression in T cells. Jurkat cells were incubated for 3 h with the wild type strain of H. pylori (P12) or
with the AC agonist PGE2 (26 mM). Foxp3 and miR-155 expression were measured by qPCR. Results are expressed as a ratio between treated and/or
infected, and mock samples. One hour prior to P12 infection, Jurkat cells were incubated with 50 mM of the irreversible AC inhibitor MDL-12,330A (AC
inh). Foxp3 expression was then assessed by Western blot (C) and FACS (D) and compared to non-infected and P12 infected cells. Foxp3 band
intensities are shown in (C). Results depicted in (C) and (D) are representative of two independent experiments. (E) miR-155 levels were measured in
H. pylori infected CCRF-CEM cells with or without the AC inhibitor (AC inh) by qPCR. Data are mean 6SD of at least four independent experiments. * p
value#0.05.
doi:10.1371/journal.pone.0009500.g005
Figure 6. H. pylori infection decreases PKIa protein levels. CCRF-
CEM cells were infected with H. pylori P12 and the mutants lacking VacA
(P12dvacA) and GGT (P12dggt) proteins and assayed for PKIa protein
levels 3 h p.i. PKIa band intensities are shown. Actin serves as a loading
control. Blots are representative of two independent experiments.
doi:10.1371/journal.pone.0009500.g006
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nuclear translocation of NFAT (nuclear factor of activated T cells),
thereby preventing T cell activation and proliferation [32]. GGT
is also secreted into the extracellular medium where it mediates the
extracellular cleavage of glutathione, leading to reactive oxygen
species production [33] and induction of a cell cycle arrest in
lymphocytes [17]. Although we observed that purified LPS alone
was sufficient to induce expression of miR-155, in mutants lacking
GGT activity (P12Dggt and P12DvacADggt) this expression was
completely suppressed. These findings indicate that the miR-155-
inducing activity of the LPS is impaired in the GGT mutants and
further suggest bacterial GGT activity plays a supportive role in
LPS-dependent miR-155 expression. However, comparison of
these results is hampered by the necessary usage of different
amounts of LPS in both experiments (500 ng/ml purified LPS vs.
bacterial LPS in an infection at MOI 100).
To provide a more complete assessment of the mechanisms of
miR-155 regulation during H. pylori infection, host transcription
factors were also investigated. The regulation of miR-155 has
recently been shown to be dependent on the activator protein 1 (AP-
1) pathway in B cells after B cell receptor activation [34] and in
primary murine macrophages [12]; however, as Foxp3 is reported to
control miR-155 expression in T cells [35], we focused on the role of
this factor. Increased numbers of Foxp3+ T cells have been found in
the gastric mucosa of H. pylori infected adenocarcinoma patients in
comparison to non-infected individuals [36]. Our study showed that
H. pylori infection induces Foxp3 expression in CD4+ cells. Using a
transient Foxp3 KD, we demonstrated that Foxp3 is mandatory for
miR-155 expression in T cells. This transcription factor was
previously considered as the master regulatory gene in regulatory
T cells. By showing that Foxp3 induces miR-155 our study hints at a
new role for Foxp3 in B cell lymphoma development.
Previous studies have suggested PGE2 could trigger Foxp3
expression in human T cells [37] and that cAMP is a component
of regulatory T cells functions [38]. Here, we showed that Foxp3
and miR-155 are induced by the AC agonist PGE2, and that
VacA and GGT could induce expression of miR-155. Both VacA
and GGT have been reported to enhance cyclo-oxygenase 2
Figure 7. Over-expression of miR-155 abolishes PKIa expression in T cells. (A) T cells were transfected with the precursor of miR-155 (Pre-
155) and a negative control (Pre-NC). The over-expression of miR-155, confirmed by qPCR (see graph), induced a dramatic decrease of PKIa protein
levels (Band intensities are shown on blot). Results are representative of two independent experiments (B) PicTar prediction of the binding of miR-155
to the 39UTR of PKIa. (C) 293T cells were transfected with a miR-155 precursor (Pre-155), miR-141 precursor (Pre-141) or the negative control (Pre-NC).
Later, the cells were transfected either with the 39UTR containing plasmid (PKIa UTR), or the miR-155 indicator plasmid (miR-155 indicator). Co-
transfection with the Renilla plasmid (pRLSV40) was achieved to normalize the data. Luciferase activities were measured. Luciferase activity is shown
as a percentage on the y-axis. miR-155 over-expression (checked by the decrease of the luciferase activity of the indicator plasmid) induces a decrease
of the firefly luciferase activity of the PKIa plasmid. Data are mean 6 SD of two independent experiments. * p value#0.05.
doi:10.1371/journal.pone.0009500.g007
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Although structurally and functionally different, the VacA and
GGT proteins might share a common feature - the elevation of
intracellular cAMP levels. Indeed, previous work has suggested
that the GGT protein modulates intracellular cAMP [17]. In
accordance, we observed that the VacA and GGT mutants did not
induce an increase in intracellular cAMP. Our results support the
notion that any cAMP inducer can activate Foxp3 and miR-155
expression. These previous observations and our new findings lead
to a model that connects H. pylori LPS and the secreted factors
VacA and GGT with an increase in intracellular cAMP and
expression of the Foxp3-miR-155 duet.
The main consequence of miRNA expression is the post-
transcriptional silencing of targeted genes. Many targets of miR-
155 have previously been described (reviewed in [40]). Bioinfor-
matic predictions designated PKIa as a putative target of miR-155.
This protein acts as a pseudo-substrate for PKA to inhibit PKA
catalytic subunits [41]. We propose the scenario in which miR-155
targets PKIa to prevent the inhibition of PKA, thereby maintaining
a positive feedback loop of its own expression. An exhaustive list
(,100) of miR-155 targets has recently been published [42]; one of
the published targets, the phosphodiesterase PDE3A, is involved in
the turnover of cAMP. Besides miR-155, Foxp3 was also shown to
support increasing levels of cAMP in immune cells [38].
Interestingly, another study suggested that PDE3B is one of the
mostFoxp3-repressed genes in regulatory T cells [43]. Foxp3 affects
the response of regulatory T cells to environmental stimuli by
modulating their cell surface and signalling molecules. Adaptation
results from the down-regulation of PDE3B to support normal
homeostasis, metabolic functions and proliferation. In addition,
previous workers have shown that Foxp3 represses, directly or
indirectly, expression of another miRNA, miR-142-3p, which
targets AC9 [44].
. Collectively, these findings draw attention to the
importance of a functional cAMP pathway in Foxp3
+ T cells.
Our study has revealed miR-155 as the only miRNA commonly
regulated by H. pylori in different cell lineages (epithelial and
hematopoietic), at least in the analysed timeframe. For the first
time in the context of H. pylori infection, the mechanisms of miR-
155 induction in T cells have been dissected. Bacterial miRNA
inducers were identified (VacA, GGT and LPS) and shown to be
activators of cAMP. In turn, cAMP was found to be necessary for
Foxp3 induction. Finally, miR-155 was shown to repress the PKA
inhibitor (PKIa) protein expression in order to facilitate contin-
uous intracellular cAMP production (see Figure S4). Taken
together, these results establish a direct link between Foxp3 and
miR-155 in human T cells and highlight the importance of cAMP
in the miR-155 induction cascade elicited by H. pylori infection.
We suggest the sequential induction of Foxp3 and miR-155 by H.
pylori keeps the cAMP pathway functional in order to achieve a
long-lasting modulation of the immune system [45].
Materials and Methods
Cell Culture and Reagents
Jurkat (ATCC, TIB-152), CCRF-CEM (ATCC, CCL-119),
J774a (DSMZ, ACC-170), MKN74 (JCRB, JCRB-0255) and AGS
(ATCC, CRL-1739) cell lines were maintained in culture in
RPMI-1640 medium supplemented with 10% heat-inactivated
FCS. HEK 293T cells (DSMZ, ACC-305) were maintained in
DMEM medium supplemented with 10% heat-inactivated FCS
and glutamine. For infection experiments, cells were starved of
growth factors overnight. BMDM were isolated from C57Bl6
mice, as previously described [46]. Human peripheral blood
monocytes (PBMCs) were isolated via the Ficoll-Hypaque density
standard procedure. Forskolin (Serva, Germany), and PGE2
(Cayman Chemical, USA, Michigan) were used at final concen-
trations of 50 and 26 mM, respectively. The AC inhibitor MDL-
12330A (Calbiochem, USA, New Jersey) was used at a final
concentration of 50 mM. The monoclonal Foxp3 and anti-b actin
antibodies were purchased from eBioscience (USA, San Diego)
and Sigma (Germany, Steinheim), respectively. The monoclonal
antibody anti-human CD4-FITC (clone MOPC-21) was obtained
from BD Pharmingen (USA, San Jose ´). The isotype control was
purchased from Becton Dickinson (USA, New Jersey). The
monoclonal antibody anti-human Foxp3-PE (clone PCH101),
the normal rat serum and the FoxP3 Staining Buffer Set were
obtained from eBioscience (USA, San Diego). The PKIa antibody
(SC-50349) was purchased from Santa Cruz Biotechnologies
(USA, Santa Cruz) and used at a 1:3000 dilution. LPS from E.coli
(InvivoGen, USA, San Diego) was used at a final concentration of
100 ng/ml. The GGT inhibitor, acivicin (A2295), was purchased
from Sigma (Germany, Steinheim) and used at a final concentra-
tion of 50 mM. The precursor of miR-155, miR-141 and the
negative control (Pre-miR negative control 1) were purchased
from Applied Biosystems (USA, Foster City).
Bacterial Strains and Infection
H. pylori strains were grown on serum plates (GC agar plates
containing 10 mg/l vancomycin, 5 mg/l trimethoprim and 2 mg/l
nystatin) in a microaerobic atmosphere at 37uC. Wild-type strains
used were P12, H. pylori 76 and SS1 (mouse adapted strains). The
P12Dggt mutant was obtained by replacing the ggt gene (Hp1118)
with a chloramphenicol resistance cassette. The double mutant
P12DvacADggt was obtained by replacing the vacA mutant ggt gene
by a kanamycin resistance cassette and grown on chloramphenicol
and kanamycin plates. The mutants P12DvacA, P12Dggt were
grown on plates supplemented with chloramphenicol. For all
experiments, cells were infected with H. pylori for 3 h at an MOI of
100. Time course experiments covered 1, 3, 6, 9 and 12 h.
Purification of Proteins and H. pylori LPS
The enzymes GGT, GGTm and the VacA protein were
purified according to published protocols [17,47]. VacA and both
GGT proteins were added onto cell lines for 3 h at 10 mg/ml.
GGT protein (1 mg) was added to human PBMCs. Before adding
to cells, the VacA protein was activated by adding 10% (v/v) of
0.2N HCl [48], then neutralized by reaching a neutral pH. VacA
and GGT preparations were tested negative for LPS contamina-
tion by using a limulus assay (LAL endosafe, Charles River, USA,
Wilmington). LPS purification from H. pylori strain P12 was
carried out as described previously [49] followed by DNase,
RNase and proteinase K treatment. Quantification of the LPS
fraction was carried out using a colorimetric based assay [50].
Heat Inactivation of Bacteria and GGT
H. pylori was inactivated by incubation at 56uC for 45 min.
Bacterial viability was then assessed by plating on GC agar plates
and colony counting for 4 days at 37uC. GGT was inactivated by
incubation at 95uC for 15 min.
Microarray Analysis
Locked nucleic acids (LNA) modified microarray capture probes
(miRCURY Probe Set, pre-release) were supplied at 480 pmol
(Exiqon, Denmark, Vedbaek). Total RNA was isolated by the
TRIzol Reagent RNA preparation method (Invitrogen, Germany,
Karlsruhe). Quality control of the RNA preparations and
quantification of total RNA amount was done using an Agilent
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NanoDrop 1000 spectrophotometer. RNA samples were labeled
with the miRCURY LNA microRNA Power Labeling Kit (Exiqon
A/S) according the supplier’s instructions. Dual color hybridiza-
tions with 0.25–1 mg RNA per Hy-dye were performed for 16 h at
60uC with hybridization buffer (Exiqon, Denmark, Vedbaek) and
LifterSlips (Erie Scientific, USA, Portsmouth). After hybridization
and washing, arrays were scanned with a DNA Microarray
Scanner BA (Agilent Technologies, USA, Santa Clara) at 5 mm
resolution. Raw microarray image data were processed with the
Image Analysis / Feature Extraction software G2567AA (Version
A.8.5.1, Agilent). The extracted GEML files were loaded onto and
analyzed with the Rosetta Resolver Biosoftware, Build 6.1 (Rosetta
Biosoftware). A color-swap dye reversal experimental setting was
applied. Ratio profiles comprising single hybridizations were
combined in an error-weighted fashion to create ratio experi-
ments. A twofold change expression cut-off for ratio experiments
was applied together with anti-correlation of ratio profiles
rendering the microarray analysis set highly significant (P-
value,0.01), robust and reproducible. The data presented in this
publication have been deposited in NCBIs Gene Expression
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are
accessible through GEO Series accession number GSE18616.
Total and Small RNA Isolation
Total RNA was harvested using TRIzol Reagent (Invitrogen,
Germany, Karlsruhe). In PBMCs, RNA was isolated with the
RNeasy kit (Invitrogen, Germany, Karlsruhe) and transcribed to
cDNA. Small RNAs (,200 nt), were isolated after resuspension in
TRIzol (Invitrogen, Germany, Karlsruhe) using the RNeasy
MinElute Cleanup kit (Qiagen, Germany, Hilden). Total RNA
from the antrum of human biopsies was isolated as described
previously [19].
qPCR
Quantitative RT-PCR for miR-155 was performed using
TaqMan miRNA assays (Applied Biosystems, USA, Foster City).
A RNU6B endogenous control was used for normalization.
Following conversion of RNA (1 mg) to cDNA, gene expression
levels were quantified using the ABI Prism 7900HT (Applied
Biosystems, USA, Foster City). Relative expression was calculated
using the comparative threshold cycle (Ct) method. Sybergreen-
based real-time qPCR was performed for Foxp3, cytokeratin 18,
CD3 and CD11c messenger RNA detection using 100 ng of total
RNA and the following gene specific primers: Foxp3 RV
(59ATTGAGTGTCCGCTGCTTCT39); Foxp3 FW (59CAAGT-
TCCACAACATGCGAC39); CK18 RV (59 TGGCTTAATGC-
CTCAGAACTTTG39); CK18 FW (59 CCACCCGCCGGA-
TAGTG39); CD3e RV (59CCCAGTCCATCCCCAGAGA39);
CD3e FW(59CCCCATCCCAAAGTATTCCA39); CD11c RV
(59TCCCTACGGGCCCCATAT39); CD11c FW (59GCCACC-
GCCATCCAAAA39). Resulting data were normalized to b actin
or GAPDH values using the following primers: b actin RV
(59CACCTTCACCGTTCCAGTTT39); b actin FW (59GATGA-
GATTGGCATGGCTTT39); GAPDH RV (59ATGCCAGT-
GAGCTTCCCGTTCAG39) and GAPDH FW (59GGTATCGT-
GGAAGGACTCATGAC39).
Generation of a Transient Foxp3 Knockdown
To silence Foxp3 expression by RNAi, CCRF-CEM cells were
seeded into a 6-well plate and transfected with 100 nM siRNAs
(Smart pool, Dharmacon, USA, Chicago) using HiPerFect
transfection reagent (Qiagen, Germany, Hilden), according to
the manufacturer’s instructions. Efficiency of gene silencing was
validated by Western Blot analysis at 48 h post-transfection.
miR-155 Over-Expression
T cells were seeded into a 6-well plate and transfected with
50 nM of miR-155 precursor or a control (Pre-miR control)
(Ambion, USA, Austin) using HiPerFect transfection reagent
(Qiagen, Germany, Hilden) following the manufacturer’s instruc-
tions. At 24 h post-transfection, over-expression was checked by
qPCR.
Luciferase Assay
A PCR fragment containing the target region of the 39U ´TR of
PKIa was ligated to the firefly luciferase plasmid pGL3-5 (a
modified pGL3 (Promega, USA, Madison) with a different
multiple cloning site). The resulting plasmid was named PKIa
UTR. The complementary sequence of hsa-miR-155 was ligated
to the pGL3-5 plasmid to obtain the ‘miR-155 indicator plasmid’.
HEK 293T cells were grown in 96-well plates and transfected
with 200 nM of miR-155 precursor (Pre-155), miR-141 precursor
(Pre-141) or the negative control (Pre-NC). Six hours later, the
cells were co-transfected using Lipofectamine 2000 (Invitrogen,
Germany, Karlsruhe) with 22.5 ng of Renilla luciferase plasmid
(pRL-SV40, Promega, USA, Madison) and either 225 ng of PKIa
UTR or the miR-155 indicator plasmid. Luciferase activities were
determined 16 h post-transfection using the Dual- Glo Luciferase
Reporter Assay (Promega, USA, Madison).
Intracellular cAMP Measurement
T cells were infected with H. pylori P12 and the single mutant
lacking the vacA and ggt genes. Forskolin was used as a positive
control. Thirty minutes post-infection, cells were collected; lysed
and intracellular cAMP levels were measured using the cAMP
Parameter EIA kit (R&D Systems, USA, Minneapolis) according
to the manufacturer’s instructions.
Western Blot
CCRF-CEM cells were lysed in Laemmli buffer. Cell lysates
(25 mg) were loaded on SDS PAGE 10% gels and proteins
transferred to PVDF membrane and blocked in TBS buffer
containing 1% Tween 20 and 3% (W/V) BSA. The anti-Foxp3
antibody was used at a 1:500 dilution; the anti-PKIa and the anti-
b actin antibodies were used at a 1:3000 dilution. Blots were
quantified using ImageJ software.
FACS Analysis
After infection, Jurkat cells were washed with PBS (supplement-
ed with 0.5%BSA/0.02%NaN3) and stained with an anti-human
CD4-FITC antibody. The intracellular staining of Foxp3 with the
anti-FoxP3-PE antibody was carried out using the Foxp3 Staining
Buffer Set (eBioscience). Ten thousand cells per sample were
analysed in a FACSCalibur flow cytometer using CellQuest
software (BD Biosciences, USA, San Jose ´).
WST1 Proliferation Assay
CCRF-CEM cells were left untreated or incubated with 50 mM
acivicin for 4 h. 1% Triton X-100 was added to untreated cells as a
negative control for viability. The WST1 assay was performed
according to the manufacturer’s instructions (Roche).
CagA Phosphorylation Assay
Gastric epithelial cells (AGS) were left non-infected or infected
for 3 h with H. pylori strain P12, the mutant P12DcagPAI and the
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Laemmli buffer (60 mM Tris, pH 6.8, 2% SDS, 10% glycerol,
0.1% bromophenol blue) and analyzed by Western blotting with
H. pylori antibody (Biomol, 1:3000), CagA antibody (Santa Cruz,
1:1000), phospho-Tyr (PY99) antibody (Santa Cruz, 1:1000) and
a-tubulin as a loading control (Sigma, 1:1000). The P12DcagPAI
mutant was used as a negative control of CagA phosphorylation.
Statistical Analysis
All statistical tests were carried out using one-way ANOVA,
followed by an unpaired Student’s t-tests using Excel (Microsoft).
Significance was set at p#0.05.
Supporting Information
Figure S1 Quantification of different cellular types in human
gastric biopsies upon H. pylori infection. Human biopsies from the
antrum of four different patients (13 to 77) were analyzed by real
time RT-PCR before (day 0) and upon 80 days (day 80) of H. pylori
infection. The experiment was carried out using cell markers such
as cytokeratin 18 for epithelial cells, CD3 for T cells and CD11c
specific of human macrophages and dendritic cells. Results showed
a slight decrease of epithelial cells, a stabilization of T cell numbers
but a very strong recruitment of macrophages and/or dendritic
cells ranging from 4 to 16 fold.
Found at: doi:10.1371/journal.pone.0009500.s001 (0.13 MB TIF)
Figure S2 cagPAI is not functional in Hp76 strain. CagA
phosphorylation was checked in AGS gastric epithelial cells upon 3
hours of infection with strains P12 and Hp76. P12DcagPAI was
used as a negative control. Lysates of non-infected (NI) and
infected cells were harvested in Laemmli buffer and probed with
H. pylori, cagA, phospho-cagA (p-CagA) and tubulin antibodies.
Western blots show that upon infection with Hp76 strain or the
P12DcagPAI mutant, no cagA phosphorylation is observed.
Found at: doi:10.1371/journal.pone.0009500.s002 (0.43 MB TIF)
Figure S3 WST1 viability assay upon acivicin treatment.
CCRF-CEM cells were untreated (NI) or incubated with 50 mM
of acivicin for 3 hours. Cells were also treated with 1% Triton X-
100 as a negative control of cellular viability. Results show that
acivicin treatment does not result in significant loss of cell
proliferation.
Found at: doi:10.1371/journal.pone.0009500.s003 (0.11 MB TIF)
Figure S4 Schematic representation of miR-155 induction by H.
pylori in human T cells. Bacterial factors including the LPS and the
secreted VacA (vacuolating toxin A) and GGT (c-glutamyl
transpeptidase) induce intracellular cAMP (cyclic adenosine
monophosphate) elevation via non-identified mechanisms.
Through a previously well-established cascade involving the
PKA (protein kinase A) and the transcription factor CREB (cAMP
responsive element-binding), cAMP elevation triggers Foxp3
(Forkhead box p3) and Cox2 (Cycoloxygenase 2) expression. On
one side, cox2 will allow PGE2 (Prostaglandin E2) formation,
which will then be secreted in order to bind to its EP2 membrane
receptor, activate the Gas protein which in turn activates
adenylate cyclase and hence increase cAMP levels. On the other
side, the Foxp3 protein will enable the formation of the BIC
transcript. Cytoplasmic export and maturation processes of this
transcript will result in miR-155 formation. miR-155 repression of
PKIa (protein kinase a inhibitor), a natural inhibitor of PKA then
facilitates intracellular cAMP production.
Found at: doi:10.1371/journal.pone.0009500.s004 (1.54 MB EPS)
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